Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review137
Machine learning-based error detection in the clinical laboratory: a critical review84
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease69
The anion gap as a predictive tool for morbidity and mortality57
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath43
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application40
Transthyretin mutagenesis: impact on amyloidogenesis and disease39
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications38
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology33
Evaluating thyroid function in pregnant women32
Beyond newborn screening: the role of reverse cascade testing in familial disease detection31
Clinical utility of human epididymis protein 431
Cardiovascular disease lipids and lipoproteins biomarker standardization29
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker27
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation25
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration25
Association of inflammatory biomarkers with morbidity and mortality risk in patients with peripheral artery disease: a systematic review and ­meta-analysis23
Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology23
Challenges of insulin-like growth factor-1 testing22
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-1922
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases22
Physiological and metabolic adaptations in pregnancy: importance of trimester-specific reference intervals to investigate maternal health and complications21
Analytical and clinical considerations of synovial fluid calprotectin in diagnosing periprosthetic joint infections20
Using a systematic approach to strategic innovation in laboratory medicine to bring about change20
Emerging applications of machine learning in genomic medicine and healthcare20
The intersection of the laboratory and transgender care18
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future18
Revisiting approaches to and considerations for urinalysis and urine culture reflexive testing17
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders16
The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor16
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?16
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis15
Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review15
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review14
Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL)13
Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?13
0.052093982696533